Search
for
Sort by
Research 781–810 of 1000+
- Guidelines for the Management of Patients with Alopecia Areata in Korea: Part I Topical and Device-based Treatment
- Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial
- SNP variation in male pattern hair loss in Russians with different dihydrotestosterone levels
- A Bibliometric Analysis of Alopecia Areata Literature over the Past 50 Years.
- Patient Profile and Treatment Characteristics of Adults and Adolescents Prescribed Ritlecitinib for Alopecia Areata in the USA
- Efficacy, safety and dose response of STS01, a topical controlled release nanoparticle formulation (dithranol/Prosilic), in adults with mild to moderate patchy alopecia areata: A randomised, double-blind, multicentre, phase 2 trial
- Novel drugs of United States Food and Drug Administration approved in 2024
- Baricitinib Provides Significant Hair Regrowth In Adolescents With Severe Alopecia Areata: 52-Week Efficacy and Safety Results From A Phase 3 Randomized, Controlled Trial
- A Systematic Literature Review of Alopecia Areata in Children and Adolescents: Psychosocial Impact
- Consider Cultural Practices and Barriers to Care When Treating Alopecia Areata
- Management of Alopecia Areata with Individualized Homoeopathy: A Case Report
- Evidence-Based Homeopathy: A case study on alopecia areata in a 6-year-old child
- New treatment modalities of alopecia areata
- Factors Affecting the Response and Patient Satisfaction of Topical Immunotherapy in Alopecia Areata: A Nationwide Study
- Gut Microbiota and Its Association with Alopecia Areata: Insights from a Two-Sample Mendelian Randomization Study
- THU0189 Safety of four treatment regimens in early rheumatoid arthritis
- Validation of the Alopecia Areata Patient Priority Outcomes (AAPPO) Questionnaire in Adults and Adolescents with Alopecia Areata
- Clinical Assessment of Alopecia Areata Severity and Validating the Patient Experience: A Vodcast
- Risk factors for the development of and outcomes after diagnosis of autoimmune alopecia areata in patients with inflammatory bowel diseases
- The Microbiome in Hair Disorders
- A Practical Approach to the Diagnosis and Management of Hair Loss in Children and Adolescents
- 1310 Anti-aging effects of retinoid hydroxypinacolone retinoate on skin models
- 1314 Advanced age impairs self-renewal and biases fate choice of hair follicle dermal stem cells
- 1315 An Integrated model of alopecia areata biomarkers highlights both Th1/Th2 upregulation, with stronger correlations between Th2 activation and disease severity
- 1312 Nrf2 activation enhances the healing of cutaneous wounds through the activation of hair follicle stem cells
- 1311 Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia
- 174 Changes in urine androgen and PG levels during finasteride treatment
- Korean Consensus Criteria for the Severity Classification of Alopecia Areata
- Alopecia Areata and Alopecia Areata Incognita
- Corrective and Restorative Dermatology in Cancer Survivors: An Urgent Unmet Need!